Rule 144: Morgan Stanley to sell 2,600 VERA shares

Morgan Stanley Smith Barney LLC submitted a Rule 144 notice to sell 2,600 shares of common stock of VERA (listed on NASDAQ).

Accepted by SEC EDGAR 02/23/2026 - 04:42 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Rule 144 notice to sell 2,600 shares of common stock of VERA (listed on NASDAQ). The sale is tied to restricted stock vesting under a registered plan with an effective date of 02/20/2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Rule 144 notice say for VERA?

The notice states that 2,600 shares of VERA common stock are to be sold under Rule 144. The sale is related to restricted stock vesting under a registered plan with an effective date of 02/20/2026.

Who is the filer on the Rule 144 for VERA?

The filer is listed as Morgan Stanley Smith Barney LLC, Executive Financial Services at 1 New York Plaza, 8th Floor, New York, NY. The filing identifies the firm as the selling party for the 2,600 shares.

What is the transaction date in the VERA Rule 144 filing?

The filing shows an effective date of 02/20/2026 for the restricted stock vesting and sale notice. The filing metadata also references 02/23/2026 as a document date.

Is the VERA sale under Rule 144 issuer- or market-based?

The filing describes the shares as arising from restricted stock vesting under a registered plan, indicating the sale relates to an issuer plan event. Specific market disposition methods are not detailed in the excerpt.

How many shares of VERA are noted in the filing?

The filing lists 2,600 shares of common stock to be sold under Rule 144 due to restricted stock vesting under a registered plan on 02/20/2026. No other share totals are explicitly described in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001819688
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERA THERAPEUTICS, INC.
SEC File Number	001-40407
Address of Issuer	8000 Marina Boulevard Suite 120 Brisbane CALIFORNIA 94005
Phone	650-770-0077
Name of Person for Whose Account the Securities are To Be Sold	WILLIAM DONALD TURNER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2600	109291.00	63928066	02/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2026	Restricted stock vesting under a registered plan	Issuer			2600	02/20/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/23/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ William D. Turner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)